Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: a …

C Tang, Y Zhang - Pathology-Research and Practice, 2024 - Elsevier
Currently, CAR-T cell therapy relies on an individualized manufacturing process in which
patient's own T cells are infused back into patients after being engineered and expanded ex …

[HTML][HTML] Natural Killer-Based Therapy: A Prospective Thought for Cancer Treatment Related to Diversified Drug Delivery Pathways

J Zang, Y Mei, S Zhu, S Yin, N Feng, T Ci, Y Lyu - Pharmaceutics, 2024 - mdpi.com
Immunotherapy has been a research hotspot due to its low side effects, long-lasting efficacy,
and wide anti-tumor spectrum. Recently, NK cell-based immunotherapy has gained broad …

Immune aging and infectious diseases

R Chen, J Zou, J Chen, L Wang, R Kang… - Chinese medical …, 2024 - mednexus.org
The rise in global life expectancy has led to an increase in the older population, presenting
significant challenges in managing infectious diseases. Aging affects the innate and …

[HTML][HTML] Peripherical Blood hsa-miR-335-5p Quantification as a Prognostic, but Not Diagnostic, Marker of Gastric Cancer

L Ramírez-Vidal, J Becerril-Rico, A Monroy-Mora… - Diagnostics, 2024 - mdpi.com
Gastric cancer (GC) is a leading cause of death, and this pathology often receives a
diagnosis in an advanced stage. The development of a less invasive and cost-effective test …